| Line Item | 2026-01-02 | Y/Y |
|---|---|---|
| Revenue | $1.47B | +5.3% |
| Cost of Revenue | $1.02B | +5.5% |
| Gross Profit | $443.2M | +4.6% |
| R&D Expense | $69.4M | +15.1% |
| SG&A Expense | $151.8M | +8.6% |
| Operating Income | -$522.9M | -1006.8% |
| Interest Expense | $53.7M | -2.3% |
| Pre-tax Income | -$576.3M | — |
| Income Tax | -$31.6M |
| Line Item | 2026-01-02 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.0M | -19.1% |
| Accounts Receivable | $190.7M | +15.0% |
| Inventory | $388.6M | -4.0% |
| Current Assets | $745.7M | +2.5% |
| Total Assets | $1.67B | -25.1% |
| Current Liabilities | $260.3M | +0.2% |
| Long-term Debt | $523.5M | -5.2% |
| Line Item | 2026-01-02 | Y/Y |
|---|---|---|
| Operating Cash Flow | $60.9M | -53.8% |
| Capital Expenditures | $34.0M | -22.9% |
| Investing Cash Flow | -$34.0M | +55.5% |
| Financing Cash Flow | -$40.0M | +40.6% |
| Free Cash Flow | $27.0M | -69.3% |
| -474.0% |
| Net Income | -$544.6M | -8414.2% |
| EPS (Basic) | -$13.03 | -8243.8% |
| EPS (Diluted) | -$13.03 | -8243.8% |
| Total Liabilities |
| $1.00B |
| -2.9% |
| Stockholders' Equity | $670.2M | -44.2% |